Magazine Article | October 2, 2023

Establishing A Research Function In Biopharma

Source: Life Science Leader

By Matthew Pillar, Editor, Bioprocess Online

For nearly 18 years, Robert Stoffel, Ph.D., was an institution at AbbVie, working his way up from principal scientist to senior director of immunology and antibody-drug conjugate over that span. That long run followed more than seven years at BMS. But late in 2021, Stoffel left the comforts of Big Bio for a new challenge with fast-moving Horizon Therapeutics.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader